Max Healthcare Institute Ltd (BSE: 543220) is a Gurugram, Haryana-based company in the Hospitals and Healthcare Centers industry. With a market capitalisation of ₹91,978 Cr, it ranks #129 by market cap among the 6,197 Indian listed companies on FinBizNet, and #2 of 46 in Hospitals and Healthcare Centers. At ₹947.10 (as of 16 Nov 2026), the share price is 20.1% below its 52-week high of ₹1,185.40 and 18.8% above its 52-week low of ₹797.00. The share price is down 16.6% over one year and down 6.5% over three months.
| Current Price | ₹947.10 |
|---|---|
| Market Cap | ₹91,978 Cr |
| BSE Code | 543220 |
| Sector | Health Care > Health Care Equipment and Services > Health Care Providers and Services |
| Sub-Industry | Health Care Facilities > Hospitals and Healthcare Centers |
| P/E Ratio | 63.9 |
| Return on Equity | 14.33% |
| Return on Assets | 6.93% |
| 52-Week Range | ₹797.00 – ₹1,185.40 |
| 1-Year Price Change | -16.6% |
| 3-Month Price Change | -6.5% |
| Beta (1Y) | 0.01 |
| Dividend Yield | 0.21% |
| Headquarters | Gurugram, Haryana |
| Website | www.maxhealthcare.in |
| Revenue | ₹2,569 Cr |
|---|---|
| Net Profit | ₹414 Cr |
| Net Margin | 16.1% |
| EPS (Basic) | ₹4.26 |
| Basis | consolidated |
Figures in ₹ crore, parsed from the company's exchange filing (XBRL).
Max Healthcare Institute Ltd reported revenue of ₹2,569 Cr in Q2 FY27, up 20.3% from ₹2,135 Cr in Q2 FY26 and up 8.6% from ₹2,366 Cr in Q1 FY27. It posted a net profit of ₹414 Cr for the quarter, against a net profit of ₹491 Cr in Q2 FY26 (down 15.6%). Across the 7 quarters from Q4 FY25 to Q2 FY27, quarterly revenue ranged from ₹1,910 Cr (Q4 FY25) to ₹2,569 Cr (Q2 FY27). The company was profitable in each of these 7 quarters.
| Quarter | Revenue | Net Profit | Net Margin |
|---|---|---|---|
| Q2 FY27 | ₹2,569 Cr | ₹414 Cr | 16.1% |
| Q1 FY27 | ₹2,366 Cr | ₹323 Cr | 13.6% |
| Q4 FY26 | ₹2,143 Cr | ₹342 Cr | 16.0% |
| Q3 FY26 | ₹2,068 Cr | ₹301 Cr | 14.6% |
| Q2 FY26 | ₹2,135 Cr | ₹491 Cr | 23.0% |
| Q1 FY26 | ₹2,028 Cr | ₹308 Cr | 15.2% |
| Q4 FY25 | ₹1,910 Cr | ₹319 Cr | 16.7% |
Consolidated figures (₹ crore, XBRL filings).
Promoters held 23.71% of Max Healthcare Institute Ltd's shares as of Sept 2026, against 23.74% in Sept 2025 (−0.03 percentage points). Delivery averaged 58.2% of traded volume across 16 NSE sessions (22 Oct 2026 – 13 Nov 2026).
Max Healthcare Institute Limited provides medical and healthcare services in India. It offers services in various specialties, including cardiac sciences, orthopedics, oncology, renal sciences, neurosciences, minimal access and general surgery, pulmonology, obstetrics, gynecology, pediatrics, and nephrology, liver and biliary sciences, gastroenterology and Gi surgery, plastic and reconstructive surgery, and organ transplants, as well as ear, nose, and throat. The company also provides Max@Home, a platform that offers health and wellness services at home; and MaxLab, which provides diagnostic services to patients outside its network of hospitals through various channels comprising third-party hospital laboratory management. It operates through a network of healthcare facilities, including hospitals and medical centres. The company was incorporated in 2001 and is based in Gurugram, India.
1. Providing Healthcare Facilities-This segment engages in the senior care business. It develops senior living facilities. 2. Leasing-This segment leases medical equipment. 3. Other than Leasing-This segment operates hospitals; constructs hospitals; and provides medical equipment repair and maintenance services. 4. Unallocated Expenses-0
1. Medical and Healthcare Services-100%
| Company | Market Cap | P/E | ROE | Latest Qtr Revenue | 1Y Change |
|---|---|---|---|---|---|
| Apollo Hospitals Enterprise Limited | ₹1,23,712 Cr | 63 | 21.50% | ₹7,615 Cr | +11.6% |
| Max Healthcare Institute Ltd | ₹91,978 Cr | 63.9 | 14.33% | ₹2,569 Cr | -16.6% |
| Manipal Health Enterprises Ltd | ₹89,110 Cr | 88.4 | — | ₹3,399 Cr | — |
| Aster Dm Healthcare Limited (Asterdm) | ₹63,041 Cr | 97.6 | 10.07% | ₹2,829 Cr | +4.3% |
| Fortis Healthcare Ltd. | ₹58,283 Cr | 55.1 | 11.01% | ₹2,735 Cr | -25.1% |
| Global Health Ltd (Medanta) | ₹38,422 Cr | 69.7 | 15.03% | ₹1,469 Cr | +16.2% |
| Narayana Hrudayalaya Limited | ₹37,907 Cr | 46.2 | 19.85% | ₹2,844 Cr | +2.8% |
| Krishna Institute Of Medical Science (KIMS) | ₹29,056 Cr | 120.6 | 9.72% | ₹1,344 Cr | +0.2% |
| Dr. Agarwal's Health Care Limited | ₹17,568 Cr | 131.9 | 8.31% | ₹655 Cr | +9.3% |
Listed by market capitalisation. Ratios are shown for context only.
Max Healthcare Institute Ltd is trading at ₹947.10, with a market capitalisation of ₹91,978 Cr.
Max Healthcare Institute Ltd operates in the Health Care > Health Care Equipment and Services > Health Care Providers and Services space (Health Care Facilities > Hospitals and Healthcare Centers).
Max Healthcare Institute Ltd has a P/E of 63.9 and a return on equity of 14.33%.
Max Healthcare Institute Ltd is listed on the BSE under the scrip code 543220.
Max Healthcare Institute Ltd's share price is down 16.6% over one year and down 6.5% over three months. Its 52-week range is ₹797.00 to ₹1,185.40.
In Q2 FY27, Max Healthcare Institute Ltd reported revenue of ₹2,569 Cr and net profit of ₹414 Cr, with basic EPS of ₹4.26 (consolidated, parsed from the company's exchange filing).
Max Healthcare Institute Ltd reported revenue of ₹2,569 Cr in Q2 FY27, up 20.3% from ₹2,135 Cr in Q2 FY26 and up 8.6% from ₹2,366 Cr in Q1 FY27.
Promoters held 23.71% of Max Healthcare Institute Ltd's shares as of Sept 2026, against 23.74% in Sept 2025 (−0.03 percentage points).
Data as of 16 Nov 2026. Descriptive market data only — not investment advice.